Evidence map›Paper›PMID 25903298›Full record

ArticleAlcoholism, clinical and experimental research2015

Effects of acamprosate on attentional set-shifting and cellular function in the prefrontal cortex of chronic alcohol-exposed mice.

Wei Hu, Brett Morris, Angelique Carrasco, Sven Kroener

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Animal Models of Excessive Alcohol Consumption in Rodents.Current topics in behavioral neurosciences · 2025
    Review
  6. Article
  7. Pre- and postsynaptic signatures in the prelimbic cortex associated with "alcohol use disorder" in the rat.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  8. Article
  9. Differential Influence ofPharmaceuticals (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review of Orbitofrontal Cortex in Alcohol Dependence: A Disrupted Cognitive Map?Alcoholism, clinical and experimental research · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Wei HuSchool of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, Texas.
Brett MorrisSchool of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, Texas.
Angelique CarrascoSchool of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, Texas.
Sven KroenerSchool of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, Texas.
The University of Texas at Dallas · US

Funding

Effects of Chronic Alcohol Exposure on Synaptic Plasticity in the Prefrontal CortR21AA017527 · NIAAA · UNIVERSITY OF TEXAS DALLAS · PI KROENER, SVEN · 2009 to 2010
$411k
NIAAA NIH HHS 1R21AA017527-01A2NIAAA NIH HHS R21 AA017527
6 · The paper itself

Abstract

backgroundThe medial prefrontal cortex (mPFC) inhibits impulsive and compulsive behaviors that characterize drug abuse and dependence. Acamprosate is the leading medication approved for the maintenance of abstinence, shown to reduce craving and relapse in animal models and human alcoholics. Whether acamprosate can modulate executive functions that are impaired by chronic ethanol (EtOH) exposure is unknown. Here we explored the effects of acamprosate on an attentional set-shifting task and tested whether these behavioral effects are correlated with modulation of glutamatergic synaptic transmission and intrinsic excitability of mPFC neurons.

methodsWe induced alcohol dependence in mice via chronic intermittent EtOH (CIE) exposure in vapor chambers and measured changes in alcohol consumption in a limited access 2-bottle choice paradigm. Impairments of executive function were assessed in an attentional set-shifting task. Acamprosate was applied subchronically for 2 days during withdrawal before the final behavioral test. Alcohol-induced changes in cellular function of layer 5/6 pyramidal neurons, and the potential modulation of these changes by acamprosate, were measured using patch clamp recordings in brain slices.

resultsChronic EtOH exposure impaired cognitive flexibility in the attentional set-shifting task. Acamprosate improved overall performance and reduced perseveration. Recordings of mPFC neurons showed that chronic EtOH exposure increased use-dependent presynaptic transmitter release and enhanced postsynaptic N-methyl-D-aspartate receptor function. Moreover, CIE treatment lowered input resistance, and decreased the threshold and the after hyperpolarization of action potentials, suggesting chronic EtOH exposure also impacted membrane excitability of mPFC neurons. However, acamprosate treatment did not reverse these EtOH-induced changes cellular function.

conclusionsAcamprosate improved attentional control of EtOH exposed animals, but did not alter the concurrent changes in synaptic transmission or membrane excitability of mPFC neurons, indicating that these changes are not the pharmacological targets of acamprosate in the recovery of mPFC functions affected by chronic EtOH exposure.

Indexed as

AcamprosateAction PotentialsAlcohol DrinkingAlcoholismAnimalsAttentionEthanolMembrane PotentialsMicePrefrontal CortexPyramidal CellsSynaptic TransmissionTaurineAcamprosateEthanolTaurineAcamprosateAlcohol AddictionAttentional Set-ShiftingPatch ClampPrefrontal Cortex

Identifiers

PMID25903298
PMCPMC10782929
OpenAlexW2094946322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.